Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | R11.1.6 |
| Synonyms | |
| Therapy Description |
R11.1.6 is a protein antagonist that preferentially binds KRAS G12D, potentially resulting in inhibition of downstream Ras signaling (PMID: 28724936, PMID: 29720559). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| R11.1.6 | KRAS Inhibitor 30 | R11.1.6 is a protein antagonist that preferentially binds KRAS G12D, potentially resulting in inhibition of downstream Ras signaling (PMID: 28724936, PMID: 29720559). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|